AltruBio lands up to $225M after shift to immune drug research

cafead

Administrator
Staff member
  • cafead   May 21, 2024 at 11:42: AM
via Biotechnology startup AltruBio on Tuesday raised a Series B round that could hand it up to $225 million, cashing in again on a decision four years ago to change its development strategy.

article source
 

<